ARCHIVES

Phase III Trial: Panobinostat Increases PFS by Four Months

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Boutwell Declines Nomination to New NCAB Term; Rowley Again Urges Appointment Of Scientists

January 20, 1984

IG Report Clears Shubik Of Conflict Of Interest Change

October 6, 1978

Stereotactic Body Radiotherapy Could Improve Overall Survival

July 29, 2011

Study Finds Hormonal Therapy Reduces Risk Of Disease Progression In Prostate Cancer

July 27, 2001

More Workers Quit Smoking When Health Messages Combined

August 30, 2002

Book Offers Info For Women Considering Ovary Removal

November 24, 2006